Everett E. Vokes to Depsipeptides
This is a "connection" page, showing publications Everett E. Vokes has written about Depsipeptides.
Connection Strength
0.162
-
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304). J Thorac Oncol. 2010 Oct; 5(10):1644-8.
Score: 0.095
-
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. Invest New Drugs. 2005 Oct; 23(5):489-93.
Score: 0.067